Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Crossiella equi

ABSTRACT: Crossiella equi overview

PROVIDER: PRJNA173295 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR18701044_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Crossiella equi NBRC 101840

Project description:Crossiella equi NBRC 101840 genome sequencing project

| PRJDB441 | ENA

Crossiella equi strain:DSM 44580 | isolate:DSM 44580

Project description:Crossiella equi DSM 44580 genome sequencing

| PRJNA696075 | ENA

Crossiella

Project description:Crossiella sp. overview

| PRJNA897068 | ENA

Investigation of the transcriptional changes associated with phenotype switching in Streptococcus equi subspecies equi strain 1691.

Project description:Streptococcus equi subspecies equi, strain 1691 grown on COBA streptococcal selective agar shows classical mucoid colony morphology in addition to a reduced capsule phenotype. This project aimed to identify changes in the transcriptional profile between the two morphologies.

2016-12-15 | E-MTAB-4147 | biostudies-arrayexpress

Prescottella equi

Project description:Rhodococcus equi overview

| PRJNA37631 | ENA

Oxyuris equi

Project description:Oxyuris equi overview

| PRJNA829186 | ENA

Ligilactobacillus equi

Project description:Lactobacillus equi overview

| PRJNA231220 | ENA

Comprehensive proteomics for Discovery vaccine candidates against Streptococcus equi Infections

Project description:Streptococcus equi subspecies equi (S. equi) is a major pathogen which cause strangles, a highly contagious respiratory infection, in horses and other equines. In this study, we purified the extracellular vesicles (EVs) of S. equi ATCC 39506 and evaluated them as vaccine candidates against S. equi infections in mice. Through immunization in an animal model and immunoprecipitation-mass spectrometry, we evaluated EV as vaccine candidates against S. equi infections and identified novel immunogenic proteins.

2021-08-06 | PXD025527 | Pride

Comprehensive proteomics for Discovery vaccine candidates against Streptococcus equi Infections

Project description:Streptococcus equi subspecies equi (S. equi) is a major pathogen which cause strangles, a highly contagious respiratory infection, in horses and other equines.In this study, we discovered potential vaccine candidates using comprehensive proteomics and reverse vaccinology. As the initial step, we divided proteome of S. equi ATCC 39506 into whole cell lysate, secretory proteome, membrane proteome and extracellular vesicle and then, comparative proteomic analysis was performed to characterize the functional features of the proteome. Especially, extracellular vesicle of S. equi was evaluated at the first time. Total 114 potential vaccine candidates (PVCs) were selected using reverse vaccinology and knowledge based annotations. Comprehensive proteomic analysis confirmed that 60 PVCs were identified in S. equi ATCC 39506. Particularly, 32 PVCs were enriched in the EV proteome, suggesting that this cellular fraction may serve as vaccine.

2021-08-06 | PXD025152 | Pride

RNA sequencing of Streptococcus equi subsp. equi collected from carrier and acute cases

Project description:Streptococcus equi subsp. equi (SEE) is a host-restricted bacterium that causes the common infectious upper respiratory disease known as strangles in horses. Perpetuation of SEE infection appears attributable to inapparent carrier horses because it does not persist long-term in the environment, infect other host mammals or vectors, and result in short-lived immunity. Whether pathogen factors enable SEE to remain in horses without causing clinical signs remains poorly understood. Thus, our objective was to use next-generation sequencing technologies to characterize the transcriptome of isolates of SEE from horses with acute clinical strangles and inapparent carrier horses to assess pathogen-associated changes that might reflect adaptions of SEE to the host contributing to inapparent carriage. RNA sequencing of SEE isolates from Pennsylvania demonstrated no genes that were differentially expressed between acute clinical and inapparent carrier isolates of SEE.

2021-05-28 | GSE167862 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data